ENTA Historical Earnings image   This ENTA historical earnings page last updated 8/10/2022
ENTA Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 20228/8/20220.02B
Q2 20225/9/20220.02B
Q1 20222/8/20220.03B
Q4 202111/22/20210.02B
Q3 20218/5/20210.02B
Q2 20215/6/20210.02B
Q1 20212/8/20210.03B
Q4 202011/23/20200.02B
Q3 20208/4/20200.02B
Q2 20205/6/20200.03B
Q1 20202/6/20200.05B
Q4 201911/21/20190.05B
Q3 20198/6/20190.04B
Q2 20195/7/20190.04B
Q1 20192/6/201969.89M
Q4 201811/26/201867.20M
Q3 20188/7/201857.26M
Q2 20185/8/201844.05M
Q1 20182/7/201838.11M
Q4 201711/20/201775.93M
Q3 20178/7/20177.51M
Q2 20175/8/20178.96M
Q1 20172/8/201710.42M
Q4 201611/21/201612.84M
Q3 20168/8/201613.98M
Q2 20165/9/201613.00M
Q1 20162/8/201648.45M
Q4 201511/23/201514.42M
Q3 20158/6/201511.60M
Q2 20155/7/201557.37M
Q1 20152/5/201577.50M
Q4 201411/24/20142.60M
Q3 20148/11/201442.10M
Q2 20145/12/20142.16M
Q1 20142/13/2014893000
Q4 201311/25/20130.00B
Q3 20138/12/20131.65M
Q2 20135/8/20131.20M
ENTA Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 20228/8/2022-1.530
Q2 20225/9/2022-1.630
Q1 20222/8/2022-1.480
Q4 202111/22/2021-1.220
Q3 20218/5/2021-1.190
Q2 20215/6/2021-1.090
Q1 20212/8/2021-0.410
Q4 202011/23/2020-1.460
Q3 20208/4/2020-0.710
Q2 20205/6/2020-0.300
Q1 20202/6/20200.650
Q4 201911/21/20190.440
Q3 20198/6/20190.330
Q2 20195/7/20190.200
Q1 20192/6/20191.25
Q4 201811/26/20181.3
Q3 20188/7/20180.97
Q2 20185/8/20180.61
Q1 20182/7/20180.78
Q4 201711/20/20171.86
Q3 20178/7/2017-0.44
Q2 20175/8/2017-0.28
Q1 20172/8/2017-0.26
Q4 201611/21/2016-0.09
Q3 20168/8/2016-0.06
Q2 20165/9/2016-0.09
Q1 20162/8/20161.36
Q4 201511/23/20150.29
Q3 20158/6/20150.13
Q2 20155/7/20151.49
Q1 20152/5/20152.18
Q4 201411/24/2014-0.27
Q3 20148/11/20142.61
Q2 20145/12/2014-0.28
Q1 20142/13/2014-0.3
Q4 201311/25/2013-0.250
Q3 20138/12/2013-0.23
Q2 20135/8/2013-2.28
Quotes delayed 20 minutes

Email EnvelopeFree ENTA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Enanta Pharmaceuticals (ENTA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ENVB Historical Earnings
ENZ Historical Earnings
EOLS Historical Earnings
EPZM Historical Earnings
EQ Historical Earnings
ERAS Historical Earnings
ESPR Historical Earnings
ETNB Historical Earnings
ETON Historical Earnings
ETTX Historical Earnings
What was the record high ENTA historical earnings result?
In terms of earnings or revenue, what is the best ENTA historical earnings result that Enanta Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest ENTA historical earnings result was set in Q3 2014, when Enanta Pharmaceuticals posted results of 2.61/share. The most successful revenue quarter within our data set was Q1 2015 when Enanta Pharmaceuticals reported revenue of 77.50M.

What was the lowest Enanta Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest ENTA has reported, and when?

✔️Accepted answer: Within our data set, the lowest ENTA historical earnings result was set in Q2 2013, when Enanta Pharmaceuticals posted results of -2.28/share. The smallest revenue quarter within our data set was Q1 2014 when Enanta Pharmaceuticals reported revenue of 893000.

On this page we presented the ENTA historical earnings date information for Enanta Pharmaceuticals. Reviewing that ENTA Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2014, when ENTA posted gaap of 2.61/share. Meanwhile the lowest ENTA historical earnings result was in Q2 2013, when ENTA posted gaap of -2.28/share. Moving to Enanta Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2015 when ENTA reported 77.50M in revenue, while the smallest revenue quarter was Q1 2014 when ENTA reported 893000 in revenue.

For self directed investors doing their due diligence on ENTA or any other given stock, their research can benefit from looking into all of the Enanta Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Enanta Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for ENTA. Thanks for visiting, and the next time you need to research ENTA historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: TBNK shares outstanding history, Top Ten Hedge Funds Holding CHIE, LBAI shares outstanding history.

 

ENTA Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.